NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 78 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2015. The put-call ratio across all filers is 97.39 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $306,000 | -17.5% | 324,140 | +16.1% | 0.00% | 0.0% |
| Q4 2015 | $371,000 | -40.7% | 279,278 | +1.8% | 0.00% | -50.0% |
| Q3 2015 | $626,000 | +41.3% | 274,392 | -0.3% | 0.00% | +100.0% |
| Q2 2015 | $443,000 | +1.6% | 275,292 | +0.5% | 0.00% | 0.0% |
| Q1 2015 | $436,000 | -17.0% | 274,016 | -1.4% | 0.00% | 0.0% |
| Q4 2014 | $525,000 | +43.8% | 278,016 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $365,000 | -10.3% | 276,827 | +0.6% | 0.00% | 0.0% |
| Q2 2014 | $407,000 | +1.8% | 275,147 | +27.1% | 0.00% | 0.0% |
| Q1 2014 | $400,000 | -10.7% | 216,447 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $448,000 | -21.4% | 216,447 | +0.6% | 0.00% | -50.0% |
| Q3 2013 | $570,000 | +2.5% | 215,247 | +3.3% | 0.00% | 0.0% |
| Q2 2013 | $556,000 | +10.8% | 208,395 | +12.4% | 0.00% | 0.0% |
| Q1 2013 | $502,000 | – | 185,355 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |